← Eichor
Study identifier: NCT05911646 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?

Condition: Apnea, Obstructive Sleep · Obstructive Sleep Apnea  ·  Sponsor: Connecticut Children's Medical Center

PhaseNA
Planned participants130
Who can joinAll sexes, 3 Years to 12 Years
Healthy volunteersYes

About this study

The concept is a novel research idea that incorporates the potential impact of patient quality of life (QOL) on decision-making for treatment of mild obstructive sleep apnea (OSA). Our hypothesis is that in children with mild OSA there is significant conflict with parental decision-making; in the absence of significant sleep apnea, there is limited research regarding comparative efficacy of various treatment options. The impact of a QOL questionnaire can be a significant deciding factor and may help guide management decisions in such situations.

This description comes directly from the study's public registry record.

Talk to the study team

Nancy Grover, MD  ·  860- 545- 9650  ·  ngrover@connecticutchildrens.org

Cameron King, MA  ·  8608375595  ·  CKing02@connecticutchildrens.org

Always discuss trial participation with your own doctor first.

Locations (1)

Connecticut Children's Medical CenterHartford, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05911646